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Recurrent reversible encephalopathy with ataxia and D-lactic acidosis in short 
bowel syndrome 
Abstract 
The short gut syndrome can lead to multiple metabolic disorders along with chronic malnutrition. 
Such patients can develop changes in mental status due to metabolic alterations. We present a 
case of an eleven-year-old male who presented to the hospital with an altered mental state. There 
were repeated admissions to the hospital with similar complaints with non-conclusive 
cerebrospinal fluid analysis and normal neuroimaging findings. The patient suffered from 
chronic malnutrition and multiple hospitalizations with altered mental status, encephalopathy. 
However, he responded well to bicarbonate therapy and prophylactic metronidazole treatment.  
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Introduction 
The post-natal or premature loss of small bowel more than fifty percent with or without large 
intestinal loss is known as short bowel syndrome (SBS). This condition can lead to lactic 
acidosis and chronic malnutrition.1 Congenital SBS usually presents as malrotation or 
gastroschisis in utero. Crohn’s disease, trauma or other multiple small bowel conditions lead to 
surgical resection of the bowel leading to SBS.2 
Case Presentation 
We present a case of an eleven-year-old male with a past medical history of 
hypocomplementemia, generalized clonic seizure (GTC), and gastroschisis, who came to the 
hospital with complaints of dizziness, confusion, and wobbly gait for twenty-four hours prior to 
the visit. The patient mentioned about passing out episodes of unspecified duration without any 
random jerking body movements. When seen by a neurology resident, the patient was alert, 
awake, oriented, and following commands without any problems. He was feeling sluggish and 
tired but was cooperative during the physical exam (Table 1). The laboratory findings have been 
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Table 1: Physical Examination and Neurological Examination 
 
Physical Exam: 
GENERAL: Lying on bed in mild distress. Followed simple commands.  
HEAD: Atraumatic and Normocephalic 
EYES: Intact extraocular movements, no nystagmus, or no eye deviation. 
Throat: Oropharynx clear. No lymphadenopathy. 
CARDIOVASCULAR: S1+S2+0, regular rate, and rhythm, no murmurs audible. 
ABDOMEN: Soft, non-tender, and non-distended bowel sounds.  
RESPIRATORY: Clear to auscultation, Symmetrical Chest expansion, No respiratory distress, 
saturating well on monitor.  
SKIN: No rash or skin deformity noted. 
Neurological Exam: 
MENTAL STATUS EXAM: Orientation: Alert, awake, and oriented x 3. Memory: Intact, 
follows simple commands. Attention/concentration: Attention span and concentration are 
normal. Language/Speech: No dysarthria/ No Aphasia. 
CRANIAL NERVES (CN): CN 2 (Optic): Intact CN 3,4,6: Pupils equal and reactive to light 
and near full eye movement without nystagmus. CN 5 (Trigeminal): Facial sensation is 
normal, no weakness of masticatory muscles. CN 7 (Facial): No facial asymmetry noted. CN 8 
(Auditory): Auditory acuity seemingly grossly normal. CN 9,10 (Glossopharyngeal/Vagus): 
The uvula is midline, the palate elevates symmetrically. CN 11 (spinal access): Normal 
sternocleidomastoid and trapezius strength. CN 12 (Hypoglossal): The tongue is midline. No 
atrophy or fasciculation. 
MOTOR: Muscle Strength: 5/5. Muscle Tone: No hypotonia/atonia/hypertonia. Muscle bulk: 
Normal. 
REFLEXES: Deep tendon reflexes - 2+ and symmetrical in all four extremities, plantar 
response present B/L, Clonus Absent, Hoffman: Absent, Cross Adductor: Not present. 
SENSATION: Intact to light touch, vibration, proprioception, vibration, fine touch  
COORDINATION: No tremor, no dysmetria. 
GAIT: Mild gait instability. 
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Table 2: Pertinent Findings and Laboratory Workup. 
Variables Values Normal Range 
Vitamin B1 (Thiamine) 153.7 66.5-200 nanomol per liter (nmol/L 
Vitamin B2 (Riboflavin) 177 137-370 microgram / liter (µg/L) 
Vitamin B3 Nicotinic 
Acid  
<5.0 0-5 nanogram/milliliter (ng/mL) 
Vitamin B3 
Nicotenamide 
18.8 5.2-72.1 nanogram/milliliter (ng/mL) 
Vitamin B6 (Pyridoxine) 28.8 5.3-46.7) microgram per liter (µg/L) 
D-Lactate 8.03 0-0.2 millimol per liter (mmol/L) 
Anion gap 19 5-14 
Thyroid-stimulating 
hormone 
3.69 0.3-3.7 milli-international units per liter (mIU/L) 
Serum chloride  116 98-108 milliequivalents per liter (mEQ/L) 
Serum zinc  73 56-134 microgram / liter (µg/L) 
 
The mother told the medical team about an episode of confusion and episodes of slurred speech 
at home. He denies any focal sensory or motor weakness except broad-based gait, which started 
on the day of the presentation. The patient also denies any urinary or bowel incontinence, vision 
changes, speech, or swallowing difficulties. Historically, the patient had seen a pediatric 
neurologist in 2018 when he was weaned off of levetiracetam after a normal 
electroencephalogram (EEG). Magnetic resonance imaging (MRI) of the brain showed no acute 
abnormality. The cerebrospinal fluid analysis was also non-contributory. In the past, the patient 
was diagnosed with a congenital condition of short gut syndrome with barium enema shown in 
Figure 1. 
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Figure 1 [A-E] Microcolon with gas-filled dilated loops of probable small bowel versus 
proximal colon and completed bowel obstruction. 
 
The patient was using a percutaneous endoscopic gastrostomy (PEG) tube for feeding and had 
persistent ileus with chronic constipation. The patient had low bicarbonate levels and low pH of 
7.3 in serum. Pediatric gastroenterology team recommended continuing the metronidazole with 
dextrose 5% in water (D5W) 1,000 milliliter (mL) + sodium bicarbonate 8.4% 150 
milliequivalent (mEq) + potassium chloride 20 mEQ. The patient took a high calorie, high 
protein, low carbohydrate diet along with vitamin B12, and zinc therapy. The laboratory workup 








Figure 2: Rising Trend of D-lactic Acidosis with Short Bowel Syndrome 
Over the years, the patient has been admitted multiple times in the hospital with this condition, 
with the rising trend observed in D-lactate levels. His sodium levels were high on admission due 
to dehydration and were normalized after intravenous hydration. The patient had normal pyruvic 
acid levels. Mentation and anion gap improved after hydration and the patient was discharged 
with metronidazole for the next three weeks. The patient’s gait instability and ataxia improved 
after one week upon discharge.  
Discussion 
Short bowel syndrome (SBS) has an incidence of two persons per million per year. It causes 
lactic acidosis due to resection of the intestine, such as Roux-en-Y gastric bypass surgery.1 SBS 
is defined as surgical resection, congenital disability, or a diseased portion of the small intestine, 
which results in the inability to maintain nutrient balances on a healthy diet.2 The small intestine 
is responsible for most of the digestion and absorption of ingested food.3 Naturally, if it were to 
get damaged, the consequences would be dire. One such effect is the accumulation of lactic acid. 
There are two different optical isomers of lactic acid; D-lactate, which results due to microbial 
flora in the intestine, and L-lactate produced from glycolysis.3 The accumulation of lactic acid 
can result from overproduction or under-excretion of the substrate. There is a wide array of 
symptoms that patients experience; these include altered mental status, neurological symptoms, 
ataxia, and slurred speech. These symptoms usually start after a high carbohydrate diet due to 
malabsorption in a patient with SBS.4 
The diagnostic criteria for lactic acidosis are a pH level of less than 7.35 and a lactate level 
higher than 5-6 mM/L.5 The accumulation of lactate results due to the undigested carbohydrates 
that reach the colon and are fermented. It can lower the intestinal pH, alter the healthy flora of 
the region, and cause an overgrowth of species, such as from the lactobacillus family. These 
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bacteria are the cause of D-lactic acidosis. To date, there is no definitive treatment for lactic 
acidosis, although recommendations include avoiding antibiotics, taking bicarbonate while 
maintaining hydration, and following a low carbohydrate diet.  
Another way to manage the refractory D-lactic acidosis is by administering insulin, vancomycin, 
neomycin, or hemodialysis.6 The report we mentioned is unique because of the refractory and 
resistant nature of lactobacillus over the year, and the rising trend of D-lactate levels in the body 
which may lead to end-organ damage and permanent neurological injury. The patient in our 
reports also falls under the metabolic encephalopathy with anion gap metabolic acidosis with 
non-contributory serum ammonia, liver, and renal profile. The metabolic encephalopathy 
occurred as a result of the accumulation of D-lactic acidosis and nutritional deficiency over the 
years with gastrointestinal problems. The limitation of our study was not collecting the gut 
microbiota for cultures since the patient was treated clinically based on diagnosis with SBS. 
There was no concern of seizure or post-ictal confusion during the current presentation with the 
past medical problem with GTC with antiepileptics weaned off almost two years ago.  
The definite management for chronic recurrent D-lactic acidosis leading to encephalopathy is 
still an area of debate and matter of future research. We conclude that in patients with short gut 
syndrome and chronic recurrent D-lactic acidosis, supportive care should improve the 
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